2017 SPEAKERS

Arooj Akhtar, Contracting Clinical Safety Scientist, GSK

Arooj Akhtar at World Drug Safety Americas 2017

Ms Laurie Anderson, Director - Safety Evaluation and Risk Management, GlaxoSmithKline

Ms Laurie Anderson at World Drug Safety Americas 2017

Nicole Baker, Director Drug Safety and EEA-QPPV, BioClinica

Mr Greg Ball, Principal Statistician, Merck & Co.

Mr Greg Ball at World Drug Safety Americas 2017

Dr Khaudeja Bano, Safety Medical Director, Abbvie

Dr Khaudeja Bano at World Drug Safety Americas 2017

Mr Arvind Bellur, Director, Head of Safety Data Management, Sanofi Inc

Mr Arvind Bellur at World Drug Safety Americas 2017

Paul Beninger, Vice President Global Patient safety, Genzyme Corporation A Sanofi Co Inc

Paul Beninger at World Drug Safety Americas 2017

Doris Beyer, Director, Pharmacovigilance, Sanofi

Doris Beyer at World Drug Safety Americas 2017

Dr William Bleker, Senior Director, PV & Safety Risk Management, Mirati Therapeutics, Inc.

Dr William Bleker at World Drug Safety Americas 2017

Mariette Boerstoel-Streefland, Head Global Safety and Pharmacovigilance, Baxalta

Mariette Boerstoel-Streefland at World Drug Safety Americas 2017

Ms Christina Budzynski, Director, Global Integration & Delivery in Global Pharmacovigilance, Otsuka America Pharmaceutical, Inc.

Mr Shaun Comfort, Associate Director and Senior Safety Science Leader, Genentech A Member of the Roche Group

Mr Shaun Comfort at World Drug Safety Americas 2017

Ms Esther de la Cuesta, Global Safety Lead, Senior Medical Director Clinical Science R&D Marketed Products Group, Takeda

Ms Esther de la Cuesta at World Drug Safety Americas 2017

Mr C.J. Delgra, Director of Global Regulatory Affairs and Safety Operations, Amgen

Mr C.J. Delgra at World Drug Safety Americas 2017

Cecilio Delgra, Executive Director, Drug Safety and Epidemiology, Novartis

Cecilio Delgra at World Drug Safety Americas 2017

Steve Dingman, Senior Medical Director, Global Pharmacovigilance, AbbVie

Steve Dingman at World Drug Safety Americas 2017

Amrit Gill, Director-Pharmacovigilance & Risk Management, Dr Reddy's Laboratories Inc

Amrit Gill at World Drug Safety Americas 2017

Mr Andres Gomez, Head of Epidemiology and Signal Detection and Data Management, Bristol Myers Squibb

Mr Andres Gomez at World Drug Safety Americas 2017

Neal Grabowski, Signal Management Officer Global Patient Safety & Labeling, Amgen

Mr William W. Gregory, Senior Director , Safety & Risk Management, Pfizer

Mr William W. Gregory at World Drug Safety Americas 2017

Dr Philip Hewitt, Global Head of early Non Clinical Safety, Merck KGaA

Kevin Holman, Senior Director, REMS Project Leader, Drug Regulatory Affairs, Actellion Pharmaceuticals Ltd

Kevin Holman at World Drug Safety Americas 2017

Mr Frank Hong, Executive Director, Drug Safety and Epidemiology, Novartis

Mr Frank Hong at World Drug Safety Americas 2017

Eric Hudimac, Associate Director, Intarcia Therapeutics Inc

Eric Hudimac at World Drug Safety Americas 2017

Mr Bob Imberman, Director Global Pharmacovigilance Strategy, Innovation and PV Intelligence, Takeda Pharmaceuticals International

Mr Bob Imberman at World Drug Safety Americas 2017

Dr Priya Jain, Medical Director, Alkermes

Dr Priya Jain at World Drug Safety Americas 2017

Jeremy Jokinen, Senior Director, Safety Decision Analytics, AbbVie

Jeremy Jokinen at World Drug Safety Americas 2017

Juhaeri Juhaeri, VP and Head, Global Safety Sciences, Sanofi

Juhaeri Juhaeri at World Drug Safety Americas 2017

Mr Robert Kane, Vice President & U.S Head, Life Science Industries, Tata Consultancy Services

Mr Robert Kane at World Drug Safety Americas 2017

Mr Kostas Kidos, VP, Head Global Drug Safety Operations, Shire

alex kim, Safety DM, Mitsubishi Tanabe Pharma Development America

alex kim at World Drug Safety Americas 2017

Ben locwin, , Biogen Idec

Dr Martha Lundberg, NIH Program Director, National Institutes of Health (NIH)

Mr Michael Lusiola, Director, Patient Safety, AstraZeneca Plc

Mr Michael Lusiola at World Drug Safety Americas 2017

Ms Marilyn Metcalf, Senior Director of Benefit Risk Evaluation, Glaxo Smith Kline

Ms Marilyn Metcalf at World Drug Safety Americas 2017

Ms Barbara Morollo, Senior Director of Pharmacovigilance and Risk Management, bluebird bio

Ms Barbara Morollo at World Drug Safety Americas 2017

Margaret Nagle, PV Operations, Dr Reddy's Laboratories

Margaret Nagle at World Drug Safety Americas 2017

Mr William O'Brien, Chairman of Medical Surveillance Team and Virology, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

Mr William O'Brien at World Drug Safety Americas 2017

Bruce Palsulich, Vice President of Product Strategy, Oracle Health Sciences

Bruce Palsulich at World Drug Safety Americas 2017

Ms Vaishali Patadia, Senior Director, Signal Management Group Lead, Sanofi-Aventis

Ms Vaishali Patadia at World Drug Safety Americas 2017

Urvi Patel, Pharmacy Fellow, Dr Reddy's Laboratories

Urvi Patel at World Drug Safety Americas 2017

Mr Sokol Petushi, Senior Director of Drug Safety and Pharmacovigilance Systems, Jazz Pharmaceuticals

Mr Sokol Petushi at World Drug Safety Americas 2017

Ms Carrie Pierce, Senior Project Manager, Epidemico

Ms Carrie Pierce at World Drug Safety Americas 2017

John Price, MD Executive Director of Risk Management and GPV, Alexion Pharmaceuticals

John Price at World Drug Safety Americas 2017

Daniel Reshef, Group Medical Director, Bristol Myers Squibb

Daniel Reshef at World Drug Safety Americas 2017

Ms Theresa Robertson, Director, Pharmacovigilance Operations, Ariad Pharmaceuticals

Ms Theresa Robertson at World Drug Safety Americas 2017

Maribel Salas, Senior Principal Scientist Medical Director, Merck and Co Inc

Maribel Salas at World Drug Safety Americas 2017

Selena Scaglione, Senior Manager, Drug Safety & Public Health, Gilead Sciences

Selena Scaglione at World Drug Safety Americas 2017

Barbara Silva-Tillmann, Senior Medical Director, Benefit Risk Management, Abbvie

Barbara Silva-Tillmann at World Drug Safety Americas 2017

Dr Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck And Company

Dr Walter Straus at World Drug Safety Americas 2017

Ms Carmit Strauss, Risk Management, Amgen

Ms Carmit Strauss at World Drug Safety Americas 2017

Ms Amy Sun, Senior Medical Director, Sanofi U.S.

Ms Amy Sun at World Drug Safety Americas 2017

Mr George Van Baelen, Head Pharmacovigilance Latin America & Caribbean, Baxalta Inc

Mr George Van Baelen at World Drug Safety Americas 2017

Mr Leonardo Viana Nicacio, Senior Global Medical Affairs Leader, AstraZeneca

Mr Leonardo Viana Nicacio at World Drug Safety Americas 2017

Susan Welsh, Chief Safety Officer, Sanofi

Susan Welsh at World Drug Safety Americas 2017

Mr Joseph Wong, Manager, Pharmacovigilance, Horizon Pharma Plc

Mr Joseph Wong at World Drug Safety Americas 2017

Mr Songlin Xue, Executive Vice President and Global Head of Pharmacovigilance, Astellas

Mr Songlin Xue at World Drug Safety Americas 2017

Hao Zhu, Associate Professor, Rutgers University